Invention Grant
- Patent Title: Quinoline-derived amide modulators of vanilloid VR1 receptor
- Patent Title (中): 喹啉衍生物的酰胺调节剂的香草素VR1受体
-
Application No.: US12174017Application Date: 2008-07-16
-
Publication No.: US08394828B2Publication Date: 2013-03-12
- Inventor: Ellen Codd , Scott L. Dax , Michele Jetter , Mark McDonnell , James J. McNally , Mark Youngman
- Applicant: Ellen Codd , Scott L. Dax , Michele Jetter , Mark McDonnell , James J. McNally , Mark Youngman
- Applicant Address: BE
- Assignee: Janssen Pharmaceutica, NV
- Current Assignee: Janssen Pharmaceutica, NV
- Current Assignee Address: BE
- Main IPC: A61K31/04
- IPC: A61K31/04 ; C07D215/38

Abstract:
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
Public/Granted literature
- US20080300236A1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR Public/Granted day:2008-12-04
Information query